Will iPS cells enhance therapeutic applicability of cord blood cells and banking?
作者:
Broxmeyer(Hal E)
状态:
发布时间2010-01-15
, 更新时间 2016-05-18
期刊:
Cell Stem Cell
摘要:
The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.